Literature DB >> 29288669

Ubiquitin chain specificities of E6AP E3 ligase and its HECT domain.

Fuminori Kobayashi1, Takumi Nishiuchi2, Kento Takaki1, Hiroki Konno3.   

Abstract

Ubiquitination of target proteins is accomplished by isopeptide bond formation between the carboxy group of the C-terminal glycine (Gly) residue of ubiquitin (Ub) and the ɛ-amino group of lysine (Lys) on the target proteins. The formation of an isopeptide bond between Ubs that gives rise to a poly-Ub chain on the target proteins and the types of poly-Ub chains formed depend on which of the seven Lys residues or N-terminal methionine (Met) residue on Ub is used for chain elongation. To understand the linkage specificity mechanism of Ub chains on E3, the previous study established an assay to monitor the formation of a free diubiquitin chain (Ub2 chain synthesis assay) by HECT type E3 ligase. In this study, we investigated Ub2 chain specificity using E6AP HECT domain. We here demonstrate the importance of the N-terminal domain of full length E6AP for Ub2 chain specificity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chain type specificity; E6AP HECT domain; Ubiquitination

Mesh:

Substances:

Year:  2017        PMID: 29288669     DOI: 10.1016/j.bbrc.2017.12.076

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.

Authors:  Stijn N V Bossuyt; A Mattijs Punt; Ilona J de Graaf; Janny van den Burg; Mark G Williams; Helen Heussler; Ype Elgersma; Ben Distel
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

2.  Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function.

Authors:  Rossella Avagliano Trezza; A Mattijs Punt; Edwin Mientjes; Marlene van den Berg; F Isabella Zampeta; Ilona J de Graaf; Yana van der Weegen; Jeroen A A Demmers; Ype Elgersma; Ben Distel
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.